Regulation of human retinal blood flow by endothelin-1

What Was Tested

This randomized controlled trial paper looks at Endothelin-1.

There is evidence from in vitro and animal studies that endothelin is a major regulator of retinal blood flow.

The researchers set out to characterize the role of the endothelin-system in the blood flow control of the human retina.

Who Took Part

The study group was 18 subjects.

PubMed indexes the participants as adults, men only.

How the Study Was Run

The researchers set it up as a randomized, double-blind, placebo-controlled and crossover study.

Because people in this Endothelin-1 study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the subjects nor the staff measuring them knew who was on Endothelin-1, so expectations could not easily colour the readings.

The comparison arm used a placebo, so changes seen with Endothelin-1 could be set against what happens without it.

In the crossover set-up each of the subjects took both Endothelin-1 and the comparison in turn, acting as their own control.

The study design was randomized, placebo-controlled, double-masked, balanced, two-way crossover in protocol A and three way-way crossover in protocol B.

What Was Measured

Measurements of retinal vessel size were done with the Zeiss retinal vessel analyzer.

Measurements of blood velocities were done with bi-directional laser Doppler velocimetry.

Topics PubMed links to this paper include Blood Pressure, Endothelin Receptor Antagonists, Endothelin-1, Hemodynamics, Laser-Doppler Flowmetry, Peptides, Cyclic and Regional Blood Flow.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Endothelin-1 in 18 subjects.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2003 (Experimental eye research), a journal based in England.

More context: the Endothelin-1 compound page, all human trials.